Keyphrases
Population-based
100%
Randomized Trial
100%
Kallikrein
100%
Clinically Significant Prostate Cancer
100%
Prostate-specific Antigen
66%
Magnetic Resonance Imaging
50%
Multiparametric MRI (mpMRI)
33%
Prostate-specific Antigen Level
33%
Reporting System
33%
Data Systems
33%
Prostate Imaging Reporting
33%
Screening Test
16%
Detection Rate
16%
Screening Protocol
16%
Magnetic Resonance Findings
16%
Screening Trials
16%
Population Screening
16%
Population-based Registry
16%
Clinically Insignificant
16%
Clinically Significant Cancer
16%
Gleason Grade Group
16%
Mortality Benefit
16%
Cancer Detection
16%
Prostate-specific Antigen Density
16%
Grade Group
16%
Stepwise Test
16%
Screening Algorithm
16%
Systematic Biopsy
16%
Negative Magnetic Resonance Imaging
16%
Targeted Biopsy
16%
4Kscore
16%
Fusion Biopsy
16%
Medicine and Dentistry
Magnetic Resonance Imaging
100%
Prostate Cancer
100%
Prostate Specific Antigen
100%
Kallikrein
100%
Biopsy Technique
66%
Malignant Neoplasm
16%
Cancer Diagnosis
16%
Gleason Score
16%
Overdiagnosis
16%
Prostate Specific Antigen Test
16%
Screening Test
16%
Blood Group A Antigen
16%
Multiparametric Magnetic Resonance Imaging
16%
Biochemistry, Genetics and Molecular Biology
Prostate-Specific Antigen
100%
Magnetic Resonance Imaging
100%
Kallikrein
85%
Gleason Score
14%
Screening Test
14%
Blood Group A Antigen
14%